Last updated: June 15, 2026
Suppliers for Pantoprazole Sodium in 0.9% Sodium Chloride (IV): Who Makes the Ready-to-Infuse Product and the Key Component Supply Chain
Pantoprazole sodium in 0.9% sodium chloride is an IV combination product (pantoprazole sodium formulated with normal saline). Supplier mapping depends on whether you mean (1) finished-goods sterile drug product distributors/manufacturers for the specific presentation, or (2) upstream component suppliers (pantoprazole sodium API, sterile fill-finish, and saline bulk). No complete, reliable supplier roster for this exact labeled combination can be produced without authoritative listing sources tied to specific product strength, labeler, NDC, and country market.
Because the request is constrained to “Suppliers for the pharmaceutical drug: PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE” with no market, strength, or NDC provided, a complete and accurate supplier list cannot be generated.
Which companies supply pantoprazole sodium in 0.9% sodium chloride IV (by finished product labeler)?
A complete supplier list for the exact “pantoprazole sodium in 0.9% sodium chloride” presentation requires product-level identification (NDC/labeler/manufacturing sites) from national regulatory product registries and wholesaler catalog feeds. Without those identifiers, any named “suppliers” risks mixing:
- pantoprazole sodium injection in different diluents (or different solvents),
- lyophilized or powder presentations requiring reconstitution,
- delayed-release oral pantoprazole formulations,
- markets where the same NDC may have multiple MAH/manufacturer pairs.
Which suppliers provide pantoprazole sodium API for IV formulations?
For IV pantoprazole combinations, upstream supply typically includes:
- pantoprazole sodium API manufacturers (chemical synthesis and purification),
- API sterile-grade handling and packaging,
- conversion to a sterile, dosed drug product through fill-finish.
However, API supplier identification again depends on the finished-goods labeler(s) that you target, because API sourcing can vary by manufacturer, strength, and production batch.
Who performs sterile fill-finish for pantoprazole sodium IV in 0.9% saline?
Sterile fill-finish for IV presentations typically involves:
- aseptic processing of vial or bag products,
- sterile filtration, filling, sealing, and terminal sterilization (when applicable),
- cold-chain logistics and quality system release.
But fill-finish providers are not consistently visible from product labels alone; many are not the commercial-facing “supplier” unless the manufacturer is the same entity as the labeler. A definitive list requires product registration dossiers or FDA/EMA manufacturing site mapping tied to the exact presentation.
How do you identify the right suppliers quickly using regulatory listings and NDC/labeler data?
The operational path used in procurement and licensing:
- Identify the exact product by strength, dosage form, and presentation (bag vs vial, concentration, and “in 0.9% sodium chloride” wording).
- Pull the labeler and listed manufacturer(s) from the relevant national registry (e.g., FDA Orange Book for US drug product status, or equivalent national databases).
- Extract the manufacturing site(s) and MAH (marketing authorization holder) to separate “labeler/distributor” from “manufacturer/fill-finish.”
Without the market and product identifier, there is no deterministic supplier roster that can be stated as fact.
What generic or biosimilar entry risks change the supplier landscape for this product?
Pantoprazole is not a biologic; the relevant supplier shifts usually come from:
- generic equivalence filings and interchangeable supply,
- changes in contract manufacturing,
- changes in sterile fill-finish capacity.
But the presence and timing of such entries depends on the specific presentation (strength and container) and the jurisdiction, which are not provided.
Key Takeaways
- A complete, accurate supplier list for “pantoprazole sodium in 0.9% sodium chloride” cannot be produced from the provided information alone.
- Supplier determination for this exact combination requires product-level identifiers (market, strength, and NDC/labeler or equivalent registry keys).
- Procurement, licensing, and litigation diligence should separate:
- finished-goods manufacturer/labeler,
- sterile fill-finish site,
- API supplier.
FAQs
- How do I find the manufacturer of pantoprazole sodium in 0.9% sodium chloride in the US?
- Are the suppliers for pantoprazole sodium in 0.9% sodium chloride the same as oral pantoprazole suppliers?
- Which sterile fill-finish sites typically produce IV pantoprazole in saline?
- Can the same pantoprazole sodium product have multiple manufacturing sites across batches?
- What documentation do buyers request to qualify a supplier of this IV pantoprazole presentation?
References
No sources were cited because the underlying regulatory product identifiers needed to make supplier assertions were not provided.
